Skip to main content
Log in

Angiotensin-converting enzyme and metals in untreated essential hypertension

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

Hpertension is an important health problem throughout the world and a risk factor for many diseases. Angiotensin-converting enzyme (ACE), a component of the renin-angiotensin system, has an important role in the regulation of blood pressure. Zinc (Zn), a trace element with important biological functions, is located in the catalytic site of ACE. Calcium (Ca), magnesium (Mg), sodium (Na), and potassium (K) also appear to be involved in hypertension pathogenesis. In this study, plasma ACE activities and Cat, Cai, Mg, Na, K, and plasma/erythrocyte Zn levels of 20 untreated patients with essential hypertension and 28 helthy individuals were evaluated. Plasma ACE activities (p<0.05) and erythrocyte Zn concentrations (p<0.001) were significantly higher in patients with essential hypertension than values of the control group. No significant difference was found between plasma Zn concentrations of the groups (p>0.05). Plasma Cat (p<0.001) and Mg levels (p<0.05) in essential hypertension were significantly lower than those of controls. Plasma Na, K, and Cai levels remained normal in essential hypertension. There are complex associations between metals and arterial pressure. Ca and Mg deficiencies seem to be associated with increased prevalence of hypertension. Increases in erythrocyte Zn may have a future potential use for diagnosis of hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. S. A. Fauci, E. Braunwald, and K. J. Isselbacher, Harrison’s Principles of Internal Medicine, 14th ed., New York (1998).

  2. J. R. Edward, R. W. Giffard, and M. D. Alderman, The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNCV), Arch. Intern. Med. 153, 154–183 (1993).

    Article  Google Scholar 

  3. R. Berkow, Hypertension, etiology and pathogenesis, in The Merck Manual (1988).

  4. J. Wyngaurde, Arterial hypertension, in Cecil Textbook of Medicine (1988).

  5. E. Zbroch, J. Malyszko, and N. Mysliwiec, New concept in pathogenesis of essential hypertension, Przegl. Lek. 56(4), 281–285 (1999).

    PubMed  CAS  Google Scholar 

  6. K. Allikmets, T. Parik, and N. Vigimau, The renin-angiotensin system in essential hypertension: associations with cardiovascular risk, Blood Press. 8(2), 70–78 (1999).

    Article  PubMed  CAS  Google Scholar 

  7. G. M. Reaven, H. Lithell, and L. Landsberg, Hypertension and associated metabolic abnormalities—the role of insulin resistance and the sympathoadrenal system, N. Engl. J. Med. 8, 374–380 (1996).

    Article  Google Scholar 

  8. A. Harjanne, Automated kinetic determination of ACE in serum, Clin. Chem. 30, 901–902 (1984).

    PubMed  CAS  Google Scholar 

  9. D. B. Milne, Trace elements, In Tietz Textbook of Clinical Chemistry, 3rd.ed., Burtis and Ashwood, eds., W. B. Saunders, Philadelphia, pp. 1029–1055 (1999).

    Google Scholar 

  10. J. B. Cali, A reference method for the determinant of calcium in serum. N.B.S. 260, 32 (1972).

    Google Scholar 

  11. Celleenananalyzer Ca 460 Kataloğu.

  12. Ciba Corning Na — K Analyzer Kataloğu. Cat No : 478639.

  13. Z. Hlubocka, V. Umnerova, S. Heller, et al., Circulating intercellular cell adhesion molecule-1 endothelin-1 and Von Willebrandt factor—markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors. J. Hum. Hypertens. 16(8), 557–562 (2002).

    Article  PubMed  CAS  Google Scholar 

  14. W. Kosmala, Endothelial dysfunction in hypertension—clinical implications, Pol. Merkuriusz Lek. 2(70), 333–335 (2002).

    Google Scholar 

  15. B. Baudin, New aspects on angiotensin-converting enzyme: from gene to disease, Clin. Chem. Lab. Med. 40(3), 256–265 (2002).

    Article  PubMed  CAS  Google Scholar 

  16. A. J. Turner, and N. M. Hooper, The angiotensin-converting enzyme gene family: genomics and pharmacology, Trends Pharmacol. Sci. 23(4), 177–183 (2002).

    Article  PubMed  CAS  Google Scholar 

  17. P. Corvol, A. Michaud, F. Soubrier, and T. A. Williams, Recent advances in knowledge of the structure and function of the angiotensin-converting enzyme, J. Hypertens. 13(Suppl. 3), 3–10 (1995).

    Article  Google Scholar 

  18. A. Bedir, N. Arik, B. Adam, K. Kilinc, T. Gumus, and E. Guner, Angiotensin converting enzyme gene polymorphism and activity in Turkish patients with essential hypertension, Am. J. Hypertens. 2(10 Pt. 1), 1038–1043 (1999).

    Article  Google Scholar 

  19. T. Tamura, G. L. Johanning, R. L. Goldenberg, R. L. Johnston, K. E. Johnston, and M. B. DuBard, Effect of angiotensin-converting enzyme gene polymorphism on pregnancy outcome, enzyme activity, and zinc concentration, Obstet. Gynecol. 88(4 Pt. 1), 497–502 (1996).

    Article  PubMed  CAS  Google Scholar 

  20. G. Vivoli, M. Bergomi, S. Rovesti, M. Pinotti, and E. Caselgrandi, Zinc, copper, and zinc- or copper-dependent enzymes in human hypertension, Biol. Trace Element Res. 49(2–3), 97–106 (1995).

    Article  CAS  Google Scholar 

  21. G. Uza, O. Pavel, A. Kovacs, D. Uza, and R. Vlaicu, Serum concentration of Na, K, Ca, Mg, P, Zn and Cu in patients with essential arterial hypertension, Clin. Exp. Hypertens. (A) 6(8), 1415–1429 (1984).

    CAS  Google Scholar 

  22. C. Russo, O. Olivieri, D. Girelli, and G. Faccini, Anti-oxidant status and lipid peroxidation in patients with essential hypertension, J. Hypertens. 16(9), 1267–1271 (1998).

    Article  PubMed  CAS  Google Scholar 

  23. S. Ripa, and R. Ripa, Zinc and arterial pressure, Minerva Med. 85(9), 455–459 (1994).

    PubMed  CAS  Google Scholar 

  24. P. Pras, J. M. Bayada, F. Bertrand, et al., The effect of various diseases on the zinc plasma level, Semin. Hop. 59(20), 1519–1522 (1983).

    CAS  Google Scholar 

  25. A. Haenni, A. Fugmann, L. Lind, and H. Lithell, Systolic blood pressure alterations during hyperinsulinemia are related to changes in ionized calcium status, Am. J. Hypertens. 14 (11 Pt. 1), 1106–1111 (2001).

    Article  PubMed  CAS  Google Scholar 

  26. M. Barbagallo, R. K. Gupta, L. J. Dominquez, and L. M. Resnick, Cellular ionic alterations with age: relation to hypertension and diabetes, J. Am Geriatr. Soc. 48(9), 1111–1116 (2000).

    PubMed  CAS  Google Scholar 

  27. J. L. Garcia Zozaya and M. Padilla Viloria, Alterations of calcium, magnessium, and zinc in essential hypertension: their relation to the renin-angiotensin-aldesterone system, Invest. Clin. 38(Suppl. 2), 27–40 (1997).

    PubMed  Google Scholar 

  28. Y. Fu, S. Wang, Z. Lu, H. Li, and S. Li, Erythrocyte and plasma Ca2+, Mg2+ and cell membrane adenosine triphosphatase activity in patients with essential hypertension, Chin. Med. J. (Engl.) 111(2), 147–149 (1998).

    CAS  Google Scholar 

  29. K. Sudhakar, M. Sujatha, V. B. Rao, A. Jyothy, and P. P. Reddy, Serum and erythrocyte magnesium levels in hypertensives and their first degree relatives, J. Indian Med. Assoc. 97(6), 211–213 (1999).

    PubMed  CAS  Google Scholar 

  30. J. A. McKnight, G. Roberts, B. Sheridan, and A. B. Atkinson, The effect of low and high sodium diets on plasma atrial natriuretic factor, the renin-aldosterone system and blood pressure in subjects with essential hypertension, Clin. Endocrinol. (Oxf). 40(1), 73–77 (1994).

    CAS  Google Scholar 

  31. L. Gesang, G. Liu, W. Cen, et al., Angiotensin-converting enzyme gene polymorphism and its association with essential hypertension in a Tibeten population, Hypertens. Res. 25(3), 481–485 (2002).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ekmekci, O.B., Donma, O. & Tunckale, A. Angiotensin-converting enzyme and metals in untreated essential hypertension. Biol Trace Elem Res 95, 203–210 (2003). https://doi.org/10.1385/BTER:95:3:203

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/BTER:95:3:203

Index Entries

Navigation